{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:58:44Z","timestamp":1785761924452,"version":"3.56.0"},"reference-count":80,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:00:00Z","timestamp":1648080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Purpose:<\/jats:bold> To determine the factors associated with opioid analgesic prescriptions as measured by community pharmacy dispensations to all Nova Scotia (NS) patients with cancer at end-of-life from 2005 to 2009.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> The NS Cancer Registry and the NS Prescription Monitoring Program (NSPMP) were used to link Nova Scotians who had a cancer diagnosis and received a prescription for opioids in their last year of life (<jats:italic>n<\/jats:italic> = 6,186) from 2005 to 2009. The association of factors with opioid dispensations at end-of-life were determined (e.g., patient demographics, type of prescriber, type of cancer, and opioid type, formulation, and dose).<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Almost 54% (<jats:italic>n<\/jats:italic> = 6,186) of the end-of-life study population with cancer (<jats:italic>n<\/jats:italic> = 11,498) was linked to the NSPMP and therefore dispensed opioids. Most prescriptions were written by general practitioners (89%) and were for strong opioids (81%). Immediate-release formulations were more common than modified-release formulations. Although the annual average parenteral morphine equivalents (MEQ) did not change during the study period, the number of opioid prescriptions per patient per year increased from 5.9 in 2006 to 7.0 in 2009 (<jats:italic>p<\/jats:italic> &amp;lt; 0.0001). Patients age 80 and over received the fewest prescriptions (mean 3.9\/year) and the lowest opioid doses (17.0 MEQ) while patients aged 40\u201349 received the most prescriptions (mean 14.5\/year) and the highest doses of opioid (80.2 MEQ).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Our study examined opioid analgesic use at end-of-life in patients with cancer for a large real-world population and determined factors, trends and patterns associated with type and dose of opioid dispensed. We provide information regarding how general practitioners prescribe opioid therapy to patients at end-of-life. Our data suggest that at the time of this study, there may have been under-prescribing of opioids to patients with cancer at end-of-life. This information can be used to increase awareness among general practitioners, and to inform recommendations from professional regulatory bodies, to aid in managing pain for cancer patients at end-of-life. Future work could address how opioid prescribing has changed over time, and whether efforts to reduce opioid prescribing in response to the opioid crisis have affected patients with cancer at end-of-life in Nova Scotia.<\/jats:p>","DOI":"10.3389\/fphar.2022.836864","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T01:05:00Z","timestamp":1648515900000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Opioid Use at End-Of-Life Among Nova Scotia Patients With Cancer"],"prefix":"10.3389","volume":"13","author":[{"given":"Laura V.","family":"Minard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Broadfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Sketris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,24]]},"reference":[{"key":"B1","volume-title":"Alberta Hospice Palliative Care Resource Manual","year":"2001"},{"key":"B2","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1200\/JCO.2015.61.0733","article-title":"Randomized Trial of Low-Dose Morphine versus Weak Opioids in Moderate Cancer Pain","volume":"34","author":"Bandieri","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jpainsymman.2018.03.010","article-title":"Comparison of Opioid Prescribing Among Cancer and Noncancer Patients Aged 18-64: Analysis Using Administrative Data","volume":"56","author":"Barbera","year":"2018","journal-title":"J. Pain Symptom Manage."},{"key":"B4","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.jpainsymman.2017.07.017","article-title":"Opioid Prescribing Among Cancer and Non-cancer Patients: Time Trend Analysis in the Elderly Using Administrative Data","volume":"54","author":"Barbera","year":"2017","journal-title":"J. Pain Symptom Manage."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1034\/j.1399-6576.2001.450902.x","article-title":"Opioids in Cancer and Chronic Non-cancer Pain Therapy-Indications and Controversies","volume":"45","author":"Breivik","year":"2001","journal-title":"Acta Anaesthesiol Scand."},{"key":"B6","unstructured":"Opioid Analgesic Use Among Nova Scotia (NS) Cancer Patients at the End-Of-Life: Results from a Population-Based Study\n            BroadfieldL.\n            FisherJ.\n            SketrisI.\n            WalshG.\n            DewarR.\n            MacIntyreM.\n          2018"},{"key":"B7","unstructured":"Opioid Analgesic Use Among Nova Scotia (NS) Cancer Patients: Results from a Population-Based Observational Study\n            BroadfieldL.\n            FisherJ.\n            SketrisI.\n            WalshG.\n          2018"},{"key":"B8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1526-4637.2006.00220.x","article-title":"Chronic Pain in the Cancer Survivor: a New Frontier","volume":"8","author":"Burton","year":"2007","journal-title":"Pain Med."},{"key":"B9","first-page":"105","volume-title":"Canadian Cancer Statistics 2010","year":"2010"},{"key":"B10","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1196\/annals.1414.033","article-title":"Cancer Pain and Analgesia","volume":"1138","author":"Christo","year":"2008","journal-title":"Ann. N. Y Acad. Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1089\/jpm.2007.9842","article-title":"The Pharmacologic Management of Cancer Pain","volume":"10","author":"Cleary","year":"2007","journal-title":"J. Palliat. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e0200071","DOI":"10.1371\/journal.pone.0200071","article-title":"Access to Hospital and Community Palliative Care for Patients with Advanced Cancer: A Longitudinal Population Analysis","volume":"13","author":"Craigs","year":"2018","journal-title":"PLoS One"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1093\/annonc\/mdn419","article-title":"Prevalence of Undertreatment in Cancer Pain. A Review of Published Literature","volume":"19","author":"Deandrea","year":"2008","journal-title":"Ann. Oncol."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s40429-018-0228-5","article-title":"The Deepening Opioid Crisis in North America: Historical Context and Current Solutions","author":"Donroe","year":"2018","journal-title":"Curr. Addict. Rep."},{"key":"B15","volume-title":"An Update on Cancer Survival","author":"Ellison","year":"2010"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1200\/JCO.21.00476","article-title":"US Trends in Opioid Access Among Patients with Poor Prognosis Cancer Near the End-Of-Life","volume":"39","author":"Enzinger","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"B17","unstructured":"Do we Need Step 2 of the WHO Pain Ladder \u2013 an EAPC Research Network Study\n            FallonM.\n          2017"},{"key":"B18","doi-asserted-by":"publisher","first-page":"iv166","DOI":"10.1093\/annonc\/mdy152","article-title":"Management of Cancer Pain in Adult Patients: ESMO Clinical Practice Guidelines","volume":"29","author":"Fallon","year":"2018","journal-title":"Ann. Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1186\/s12913-017-2354-5","article-title":"Evaluating the Impact of Prescription Drug Monitoring Program Implementation: a Scoping Review","volume":"17","author":"Finley","year":"2017","journal-title":"BMC Health Serv. Res."},{"key":"B20","article-title":"Opioid Use Among Nova Scotia Cancer Patients: Methodology for a Population-Based Observational Study. Poster Session Presented at: the Beatrice Hunter Cancer Research Institute 3rd Annual Cancer Research Conference in Atlantic Canada. Halifax, NS","volume":"7","author":"Fisher","year":"2011","journal-title":"November"},{"key":"B21","unstructured":"The Impact of Age on the Prevalence and Dose of Opioid Analgesics in Patients with Cancer at End-Of-Life: A Population Based Study\n            FisherJ.\n            BroadfieldL.\n            SketrisI.\n            WalshG.\n          2018"},{"key":"B22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/pds.2259","article-title":"The Effect of an Educational Intervention on Meperidine Use in Nova Scotia, Canada: a Time Series Analysis","volume":"21","author":"Fisher","year":"2012","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"B23","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1155\/2014\/634171","article-title":"Overview of Four Prescription Monitoring\/review Programs in Canada","volume":"19","author":"Furlan","year":"2014","journal-title":"Pain Res. Manag."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.jpainsymman.2021.03.025","article-title":"Decreasing Trends in Opioid Prescribing on Discharge to Hospice Care","volume":"62","author":"Furuno","year":"2021","journal-title":"J. Pain Symptom Manage."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e79266","DOI":"10.1371\/journal.pone.0079266","article-title":"Managing Cancer Pain at the End of Life with Multiple strong Opioids: A Population-Based Retrospective Cohort Study in Primary Care","volume":"9","author":"Gao","year":"2014","journal-title":"PLoS One"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1164\/rccm.201803-0592OC","article-title":"End-of-life Strategies Among Patients with Advanced Chronic Obstructive Pulmonary Disease","volume":"198","author":"Gershon","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B27","unstructured":"International Association for the Study of Pain2015"},{"key":"B28","volume-title":"Recalls and Safety Alerts. Important Changes to the Dose Conversion Guidelines for Fentanyl Transdermal Systems \u2013 for Health Professionals","year":"2009"},{"key":"B29","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3322\/caac.20032","article-title":"Current Status of Palliative Care-Cclinical Implementation, Education, and Research","volume":"59","author":"Grant","year":"2009","journal-title":"CA Cancer J. Clin."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1200\/GO.21.00141","article-title":"National Study of Pain Medicine Access Among M\u0101ori and Non-m\u0101ori Patients with Lung Cancer in New Zealand","volume":"7","author":"Gurney","year":"2021","journal-title":"JCO Glob. Oncol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1001\/jama.2014.18514","article-title":"Mandatory Use of Prescription Drug Monitoring Programs","volume":"313","author":"Haffajee","year":"2015","journal-title":"JAMA"},{"key":"B32","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1054\/bjoc.2001.1680","article-title":"Morphine and Alternative Opioids in Cancer Pain: the EAPC Recommendations","volume":"84","author":"Hanks","year":"2001","journal-title":"Br. J. Cancer"},{"key":"B33","volume-title":"Subsection 56(1) Class Exemption for Patients, Practitioners and Pharmacists Prescribing and Providing Controlled Substance in Canada during the Coronavirus Pandemic","year":"2020"},{"key":"B34","volume-title":"Appeal to Physicians \u2013 Opioids Have Their Place: Let\u2019s Avoid an Unintended Tragedy!","author":"Henderson","year":"2017"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e110457","DOI":"10.1371\/journal.pone.0110457","article-title":"Assessing and Responding to Palliative Care Needs in Rural Sub-saharan Africa: Results from a Model Intervention and Situation Analysis in Malawi","volume":"9","author":"Herce","year":"2014","journal-title":"PLoS One"},{"key":"B36","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jpainsymman.2010.09.022","article-title":"A Shared Care Model Pilot for Palliative home Care in a Rural Area: Impact on Symptoms, Distress, and Place of Death","volume":"42","author":"Howell","year":"2011","journal-title":"J. Pain Symptom Manage."},{"key":"B37","unstructured":"Nova Scotia Cancer Registry Profile Page2018"},{"key":"B38","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.pmn.2012.06.002","article-title":"Barriers to Cancer Pain Management in Danish and Lithuanian Patients Treated in Pain and Palliative Care Units","volume":"15","author":"Jacobsen","year":"2014","journal-title":"Pain Manag. Nurs."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e1003829","DOI":"10.1371\/journal.pmed.1003829","article-title":"Opioid Prescribing Among New Users for Non-cancer Pain in the USA, Canada, UK, and Taiwan: A Population-Based Cohort Study","volume":"18","author":"Jani","year":"2021","journal-title":"Plos Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.jpainsymman.2004.07.010","article-title":"Use of Opioids in a Danish Population-Based Cohort of Cancer Patients","volume":"29","author":"Jarlbaek","year":"2005","journal-title":"J. Pain Symptom Manage."},{"key":"B41","doi-asserted-by":"publisher","first-page":"v257","DOI":"10.1093\/annonc\/mdq224","article-title":"Management of Cancer Pain: ESMO Clinical Practice Guidelines","volume":"21","author":"Jost","year":"2010","journal-title":"Ann. Oncol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1038\/sj.bjc.6601086","article-title":"Summary Version of the Standards, Options and Recommendations for the Use of Analgesia for the Treatment of Nociceptive Pain in Adults with Cancer (Update 2002)","volume":"89","author":"Krakowski","year":"2003","journal-title":"Br. J. Cancer"},{"key":"B43","doi-asserted-by":"publisher","first-page":"57","DOI":"10.4103\/0973-1075.78451","article-title":"Reporting Characteristics of Cancer Pain: a Systematic Review and Quantitative Analysis of Research Publications in Palliative Care Journals","volume":"17","author":"Kumar","year":"2011","journal-title":"Indian J. Palliat. Care"},{"key":"B44","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/bcp.13792","article-title":"Prevalence and Incidence of Prescription Opioid Analgesic Use in Australia","volume":"85","author":"Lalic","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1089\/jpm.2020.0640","article-title":"Integrative Palliative Care Service Model Improved End-Of-Life Care and Overall Survival of Advanced Cancer Patients in Hong Kong: A Review of Ten-Year Territory-wide Cohort","volume":"24","author":"Lam","year":"2021","journal-title":"J. Palliat. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1038\/sj.bjc.6601365","article-title":"Comparison of Sustained-Release Morphine with Sustained-Release Oxycodone in Advanced Cancer Patients","volume":"89","author":"Lauretti","year":"2003","journal-title":"Br. J. Cancer"},{"key":"B47","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s11916-011-0201-7","article-title":"Pain Management in Patients with Cancer: Focus on Opioid Analgesics","volume":"15","author":"Leppert","year":"2011","journal-title":"Curr. Pain Headache Rep."},{"key":"B48","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/PPO.0b013e31818f5aa7","article-title":"Management of Chronic Pain in Cancer Survivors","volume":"14","author":"Levy","year":"2008","journal-title":"Cancer J."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1007\/s00520-017-3682-z","article-title":"Mapping French People and Health Professionals' Positions Regarding the Circumstances of Morphine Use to Relieve Cancer Pain","volume":"25","author":"Mazoyer","year":"2017","journal-title":"Support Care Cancer"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e889","DOI":"10.1200\/JOP.2017.021683","article-title":"End-of-life Services Among Patients with Cancer: Evidence from Cancer Registry Records Linked with Commercial Health Insurance Claims","volume":"13","author":"McDermott","year":"2017","journal-title":"J. Oncol. Pract."},{"key":"B51","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jpainsymman.2018.10.493","article-title":"Managing Chronic Pain in Cancer Survivors Prescribed Long-Term Opioid Therapy: A National Survey of Ambulatory Palliative Care Providers","volume":"57","author":"Merlin","year":"2019","journal-title":"J. Pain Symptom Manage."},{"key":"B52","doi-asserted-by":"publisher","first-page":"e026705","DOI":"10.1136\/bmjopen-2018-026705","article-title":"Tramadol and the Risk of Seizure: Nested Case-Control Study of US Patients with Employer-Sponsored Health Benefits","volume":"9","author":"Morrow","year":"2019","journal-title":"BMJ Open"},{"key":"B53","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/SPC.0000000000000565","article-title":"Serious Health-Related Suffering and Palliative Care in South Asian Countries","volume":"15","author":"Nambiar","year":"2021","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"B54","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1001\/jamainternmed.2014.5260","article-title":"Tramadol and Hypoglycemia: One More Thing to Worry about","volume":"175","author":"Nelson","year":"2015","journal-title":"JAMA Intern. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1200\/GO.21.00122","article-title":"mPalliative Care Link: Examination of a mobile Solution to Palliative Care Coordination Among Tanzanian Patients with Cancer","volume":"7","author":"Ngoma","year":"2021","journal-title":"JCO Glob. Oncol."},{"key":"B56","unstructured":"About Us: History2017"},{"key":"B57","volume-title":"BC Guidelines [Internet]","year":"2017"},{"key":"B58","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jpainsymman.2012.02.014","article-title":"Trends in the Consumption of Opioid Analgesics in Taiwan from 2002 to 2007: a Population-Based Study","volume":"45","author":"Pan","year":"2013","journal-title":"J. Pain Symptom Manage."},{"key":"B59","volume-title":"Special Advisory Committee on the Epidemic of Opioid Overdoses","author":"Pan-Canadian Public Health Network","year":"2021"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1097\/j.pain.0000000000001242","article-title":"Clinical Indications Associated with Opioid Initiation for Pain Management in Ontario, Canada: A Population-Based Cohort Study","volume":"159","author":"Pasricha","year":"2018","journal-title":"Pain"},{"key":"B61","volume-title":"Equianalgesic Dosing of Opioids for Pain Management","year":"2012"},{"key":"B62","first-page":"1855","article-title":"Opioids for Management of Breakthrough Pain in Cancer Patients","volume":"74","author":"Potter","year":"2006","journal-title":"Am. Fam. Physician"},{"key":"B63","doi-asserted-by":"publisher","first-page":"vi69","DOI":"10.1093\/annonc\/mdr390","article-title":"Management of Cancer Pain: ESMO Clinical Practice Guidelines","author":"Ripamonti","year":"2011","journal-title":"Ann. Oncol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/j.1526-4637.2009.00621.x","article-title":"Opioid Use in an Israeli Health Maintenance Organization: 2000-2006","volume":"10","author":"Shvartzman","year":"2009","journal-title":"Pain Med."},{"key":"B65","volume-title":"Prescription Monitoring Programs in Canada: Best Practice and Program Review","author":"Sproule","year":"2015"},{"key":"B66","unstructured":"The 10 Leading Causes of Death2012"},{"key":"B67","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1093\/ajhp\/61.3.277","article-title":"Evaluation of a Pharmacist Pain Management Education Program and Associated Medication Use in a Palliative Care Population","volume":"61","author":"Suh","year":"2004","journal-title":"Am. J. Health Syst. Pharm."},{"key":"B68","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.bulcan.2021.08.006","article-title":"Opioid Prescriptions in Bone Metastatic Cancer Patients: A Cross Sectional Nationwide Pharmacoepidemiological Study","volume":"108","author":"Tarot","year":"2021","journal-title":"Bull. Cancer"},{"key":"B69","volume-title":"Concept Dictionary and Glossary. Term: Prescribed Daily Dose (PDD)","year":"2005"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/annonc\/mdm056","article-title":"Prevalence of Pain in Patients with Cancer: a Systematic Review of the Past 40 Years","volume":"18","author":"van den Beuken-van Everdingen","year":"2007","journal-title":"Ann. Oncol."},{"key":"B71","volume-title":"Victoria\u2019s End of Life and Palliative Care Framework","year":"2016"},{"key":"B72","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/9781119413431.ch18","article-title":"Studies of Drug Utilization","volume-title":"Studies of Drug Utilization\u201d in Pharmacoepidemiology","author":"Wettermark","year":"2019"},{"key":"B73","volume-title":"Definitions and General Considerations","year":"2009"},{"key":"B74","doi-asserted-by":"publisher","first-page":"CD012592","DOI":"10.1002\/14651858.CD012592.pub2","article-title":"Opioids for Cancer Pain - an Overview of Cochrane Reviews","volume":"7","author":"Wiffen","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1111\/j.1526-4637.2010.00977.x","article-title":"Computerized Progress Notes for Chronic Pain Patients Receiving Opioids; the Prescription Opioid Documentation System (PODS)","volume":"11","author":"Wilsey","year":"2010","journal-title":"Pain Med."},{"key":"B76","volume-title":"Cancer Pain Relief: With a Guide to Opioid Availability","year":"1996"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.jpainsymman.2019.02.023","article-title":"Patient Patterns and Perspectives on Using Opioid Regimens for Chronic Cancer Pain","volume":"57","author":"Wright","year":"2019","journal-title":"J. Pain Symptom Manage."},{"key":"B78","doi-asserted-by":"publisher","first-page":"E352","DOI":"10.1503\/cmaj.121592","article-title":"Tramadol","volume":"185","author":"Young","year":"2013","journal-title":"Cmaj"},{"key":"B79","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1097\/j.pain.0000000000000656","article-title":"Opioid Prescribing for Patients with Cancer in the Last Year of Life: A Longitudinal Population Cohort Study","volume":"157","author":"Ziegler","year":"2016","journal-title":"Pain"},{"key":"B80","doi-asserted-by":"publisher","first-page":"e018284","DOI":"10.1136\/bmjopen-2017-018284","article-title":"Is Palliative Care Support Associated with Better Quality End-Of-Life Care Indicators for Patients with Advanced Cancer? A Retrospective Cohort Study","volume":"8","author":"Ziegler","year":"2018","journal-title":"BMJ Open"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.836864\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T01:05:29Z","timestamp":1648515929000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.836864\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,24]]},"references-count":80,"alternative-id":["10.3389\/fphar.2022.836864"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.836864","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,24]]},"article-number":"836864"}}